DH

DH

USD

Definitive Healthcare Corp. Class A Common Stock

$2.710+0.020 (0.743%)

Prix en Temps Réel

Healthcare
Health Information Services
États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$2.690

Haut

$2.730

Bas

$2.647

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

292.6M

Industrie

Health Information Services

Pays

United States

Statistiques de Trading

Volume Moyen

1.10M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $2.15Actuel $2.710Haut $7.471

Rapport d'Analyse IA

Dernière mise à jour: 27 avr. 2025
Généré par l'IASource des Données: Yahoo Finance, Bloomberg, SEC

DH (Definitive Healthcare Corp. Class A Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: DH Generate Date: 2025-04-27 22:23:28

Alright, let's break down what's been happening with Definitive Healthcare stock lately and what the data we have might suggest. This company, remember, is all about selling data and software to folks in the healthcare world – think hospitals, drug companies, device makers, and so on. It's a specific niche, and not a giant company by market cap standards (around $292 million).

Recent News Buzz

What's the story from the latest headlines? We've got two main bits of news here.

First, the company announced when they'll be sharing their financial results for the first quarter of 2025. This is pretty standard stuff for a public company; they have to tell everyone how they did. It doesn't tell us how they did, just when we'll find out.

The second piece of news is more interesting. Definitive Healthcare reported giving out some special stock grants as part of hiring a new senior person. Bringing in senior talent is usually seen as a positive step for a company. It suggests they're investing in leadership and potentially looking to boost performance or strategy. So, while the earnings call timing is neutral, the hiring news leans a bit positive.

Checking the Price Action

Now, let's look at what the stock price itself has been doing over the past month or so. Looking at the chart data, things got pretty rough for DH. Towards the end of March, the stock was trading around the $2.90 to $3.00 mark. Then, right at the start of April, it took a significant tumble. It dropped sharply and even hit a 52-week low of $2.15 around April 9th.

Since hitting that low point, the price has managed to bounce back somewhat. It's been trading mostly between $2.40 and $2.70, and it closed recently right at $2.71. So, the big picture over the last month is a sharp decline followed by a modest recovery off the absolute lows.

What about the very near future? The AI prediction model we have suggests the price might stay flat today (0.00% change predicted), but then it sees a couple of slightly positive days ahead, predicting a 1.41% increase the next day and a 2.79% increase the day after that.

Putting It All Together: Outlook & Ideas

So, where does that leave us? We've got a stock that's been hammered but recently bounced off its yearly low. The latest news includes a positive note about hiring, and the AI is forecasting a small upward move in the immediate future. The recommendation data we have also flags DH with a moderately positive score, calling it a potential "Undervalued Gem" and noting positive technical signs like trading volume and a bullish trend indicator (DMI), alongside the positive news sentiment and AI prediction. It does point out fundamental challenges like negative growth and high debt, plus a low P/E ratio which could be seen as cheap or a sign of trouble depending on your view.

Given the bounce from the lows, the slightly positive news, and the AI's short-term forecast, the immediate leaning here seems to be away from further sharp declines, at least for the moment. It might suggest a 'hold' if you're already in, or perhaps looking for potential entry points if you're not.

If someone were considering getting in based on this data, the recommendation system points to potential entry levels around $2.70 to $2.73. The current price is right in that zone ($2.71). This level is also where the stock has been trading recently after its bounce.

For managing risk, the recommendation data offers some ideas. A potential stop-loss level is suggested at $2.45. This is below the recent trading range and well below the current price, giving the stock some room to move but setting a point to cut losses if the recent recovery fails and it heads back towards or below the April lows. On the upside, a potential take-profit level is mentioned at $2.94. This is near where the stock was trading before its big drop in early April and could act as a short-term target if the predicted upward movement materializes.

Remember, this is just an interpretation based on the data provided right now. Market conditions can change fast, and this stock has shown it can be quite volatile.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Investing in stocks involves risk, and you could lose money. Always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Actualités Connexes

GlobeNewswire

Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report

Voir plus
Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
GlobeNewswire

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior

Voir plus
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Prédiction IABeta

Recommandation IA

Haussier

Mis à jour le: 28 avr. 2025, 09:39

BaissierNeutreHaussier

63.5% Confiance

Risque et Trading

Niveau de Risque4/5
Risque Élevé
Adapté Pour
Valeur
Guide de Trading

Point d'Entrée

$2.70

Prise de Bénéfices

$2.94

Stop Loss

$2.45

Facteurs Clés

Le PDI 14.1 est au-dessus du MDI 10.4 avec un ADX de 12.3, suggérant une tendance haussière
Le cours actuel est extrêmement proche du niveau de support ($2.71), suggérant une forte opportunité d'achat
Le volume de transactions est 3.0x la moyenne (13,247), indiquant une pression d'achat extrêmement forte
Le MACD 0.0019 est en dessous de la ligne de signal 0.0027, indiquant un croisement baissier

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.